{"id":"https://openalex.org/W2084797936","doi":"https://doi.org/10.1158/1078-0432.ccr-10-3366","title":"Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment","display_name":"Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment","alternate_titles":[],"publication_year":2011,"publication_date":"2011-03-15","ids":{"openalex":"https://openalex.org/W2084797936","doi":"https://doi.org/10.1158/1078-0432.ccr-10-3366","mag":"2084797936","pmid":"https://pubmed.ncbi.nlm.nih.gov/21411438"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-10-3366","doi":"https://doi.org/10.1158/1078-0432.ccr-10-3366","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-3366","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2084797936"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Author's Affiliation: Dana-Farber Cancer Institute, Medical Oncology, Boston, Massachusetts","Dana-Farber Cancer Institute, Medical Oncology, Boston, Massachusetts 02115, USA. kenneth_anderson@dfci.harvard.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Author's Affiliation: Dana-Farber Cancer Institute, Medical Oncology, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Medical Oncology, Boston, Massachusetts 02115, USA. kenneth_anderson@dfci.harvard.edu","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032464400"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":4.7922,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.95468056,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"17","issue":"6","first_page":"1225","last_page":"1233"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.9879999756813049},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9359999895095825},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.906000018119812},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.6039999723434448},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6589999794960022},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/translational-research","display_name":"translational research","score":0.546999990940094},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7600936889648438},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7063720226287842},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6640185713768005},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6284762024879456},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.581728458404541},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5163429975509644},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45257917046546936},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.44513991475105286},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38351595401763916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2862791419029236}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001842","descriptor_name":"Bone and Bones","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023281","descriptor_name":"Genomics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-10-3366","doi":"https://doi.org/10.1158/1078-0432.ccr-10-3366","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-3366","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:21411438","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21411438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":83,"referenced_works":["https://openalex.org/W66356296","https://openalex.org/W1537635966","https://openalex.org/W1600462418","https://openalex.org/W1884682701","https://openalex.org/W1966704794","https://openalex.org/W1969648097","https://openalex.org/W1974983065","https://openalex.org/W1980471295","https://openalex.org/W1986036865","https://openalex.org/W1987583882","https://openalex.org/W1992538067","https://openalex.org/W1997686829","https://openalex.org/W1998854709","https://openalex.org/W2000047150","https://openalex.org/W2000655497","https://openalex.org/W2004543856","https://openalex.org/W2010552629","https://openalex.org/W2012959199","https://openalex.org/W2021954218","https://openalex.org/W2029006246","https://openalex.org/W2031157863","https://openalex.org/W2033944464","https://openalex.org/W2041236924","https://openalex.org/W2049150145","https://openalex.org/W2052169053","https://openalex.org/W2053706526","https://openalex.org/W2056320810","https://openalex.org/W2058195404","https://openalex.org/W2060496777","https://openalex.org/W2060630093","https://openalex.org/W2063827408","https://openalex.org/W2066800926","https://openalex.org/W2066936999","https://openalex.org/W2067134630","https://openalex.org/W2078607428","https://openalex.org/W2086990334","https://openalex.org/W2096207943","https://openalex.org/W2099110265","https://openalex.org/W2103011422","https://openalex.org/W2103114868","https://openalex.org/W2104148554","https://openalex.org/W2104494161","https://openalex.org/W2106101491","https://openalex.org/W2108235071","https://openalex.org/W2119462367","https://openalex.org/W2119810076","https://openalex.org/W2120780398","https://openalex.org/W2122209792","https://openalex.org/W2124560610","https://openalex.org/W2127760782","https://openalex.org/W2132013899","https://openalex.org/W2133986577","https://openalex.org/W2136810538","https://openalex.org/W2138102966","https://openalex.org/W2138230649","https://openalex.org/W2142149038","https://openalex.org/W2144531125","https://openalex.org/W2146502962","https://openalex.org/W2148537814","https://openalex.org/W2149386327","https://openalex.org/W2150821792","https://openalex.org/W2150997370","https://openalex.org/W2151595053","https://openalex.org/W2155165473","https://openalex.org/W2156381278","https://openalex.org/W2158599261","https://openalex.org/W2158838447","https://openalex.org/W2159860846","https://openalex.org/W2162468902","https://openalex.org/W2163999353","https://openalex.org/W2164706843","https://openalex.org/W2166268863","https://openalex.org/W2166427186","https://openalex.org/W2169774815","https://openalex.org/W2170192548","https://openalex.org/W2170515647","https://openalex.org/W2262404842","https://openalex.org/W2274695769","https://openalex.org/W2325302070","https://openalex.org/W2466643439","https://openalex.org/W2520815307","https://openalex.org/W2599726035","https://openalex.org/W3143387670"],"related_works":["https://openalex.org/W2161160225","https://openalex.org/W2063355387","https://openalex.org/W2041448202","https://openalex.org/W2525260054","https://openalex.org/W1885204825","https://openalex.org/W2010552629","https://openalex.org/W2352566029","https://openalex.org/W2057819044","https://openalex.org/W1975774320","https://openalex.org/W4309686345"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1],"(MM)":[2],"is":[3,36],"an":[4],"example":[5],"of":[6,71,90,98,103],"rapid":[7],"bench-to-bedside":[8],"translation":[9],"in":[10,21,30,78,107,115,132],"new":[11],"drug":[12,28],"development.":[13],"Bortezomib":[14],"and":[15,32,44,48,65,69,88,124,136],"lenalidamide":[16],"target":[17],"the":[18,22,75,105],"tumor":[19,76,106],"cell":[20,77],"bone":[23],"marrow":[24],"microenvironment":[25,109],"to":[26,38,93,119,121,128],"overcome":[27],"resistance":[29],"laboratory":[31],"animal":[33],"models;":[34],"each":[35],"effective":[37],"treat":[39],"relapsed":[40],"and/or":[41],"refractory,":[42],"relapsed,":[43],"newly":[45],"diagnosed":[46],"MM,":[47],"both":[49],"are":[50],"now":[51],"showing":[52],"promise":[53],"as":[54,139],"maintenance":[55],"therapy.":[56],"Major":[57],"ongoing":[58],"translational":[59],"research":[60],"efforts":[61],"include":[62],"improved":[63],"classification":[64],"personalized":[66],"therapies;":[67,83,87],"identification":[68],"validation":[70],"next-generation":[72],"agents":[73,92],"targeting":[74,104],"its":[79,108],"microenvironment;":[80],"novel":[81,91],"immune":[82],"rationally":[84],"based":[85],"combination":[86],"use":[89],"delay":[94],"or":[95],"prevent":[96],"development":[97],"active":[99],"MM.":[100],"This":[101],"paradigm":[102],"has":[110,125],"already":[111],"extended":[112],"median":[113],"survival":[114],"MM":[116],"from":[117],"3":[118],"7":[120],"8":[122],"years":[123],"great":[126],"potential":[127],"improve":[129],"patient":[130],"outcome":[131],"other":[133],"hematologic":[134],"malignancies":[135],"solid":[137],"tumors":[138],"well.":[140]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2084797936","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
